“A.B.C.” of Immunotherapy in Hematological Malignancies…Promise and Perils
The treatment landscape of hematological malignancies has been evolving at an extremely fast pace. Hematological malignancies are diverse and distinct from solid tumors. These constitute challenges, which are also unique opportunities for immunotherapy. The five categories of immunotherapies that ha...
Saved in:
| Main Authors: | Jyoti Bajpai, Deepa Susan Joy Philip |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2024-04-01
|
| Series: | Indian Journal of Medical and Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1749321 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
by: Haiqiong Zheng, et al.
Published: (2024-11-01) -
Editorial: Immunotherapy: up to date progress in childhood and hematological malignancies
by: Kishore B. Challagundla, et al.
Published: (2025-03-01) -
The efficacy and safety of CD7 chimeric antigen receptor T-cell therapy for hematologic malignancies: a systematic review and meta-analysis
by: Jile Liu, et al.
Published: (2025-01-01) -
Targeting myeloid cells for hematological malignancies: the present and future
by: Zihui Guan, et al.
Published: (2025-04-01) -
Advances in CAR-T cell therapy for hematologic and solid malignancies: latest updates from 2024 ESMO Congress
by: Huageng Huang, et al.
Published: (2024-12-01)